Valuation: Becton, Dickinson and Company

Market Cap 48.5B 43.1B 40.22B 36.66B 69.14B 4,663B 69.79B 487B 189B 2,384B 182B 178B 7,650B P/E 2026 *
34.1x
P/E 2027 * 19x
Enterprise Value 64.39B 57.21B 53.4B 48.67B 91.79B 6,190B 92.64B 646B 250B 3,164B 242B 236B 10,156B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.17x
Free-Float
73.18%
Yield 2026 *
2.22%
Yield 2027 * 2.26%
1 week+0.64%
Current month-0.25%
1 month-1.80%
3 months+18.01%
6 months+17.09%
Current year+20.23%
1 week 155.75
Extreme 155.75
161.8
1 month 151.05
Extreme 151.05
164.15
3 years 114.84
Extreme 114.84280575
199.55
5 years 114.84
Extreme 114.84280575
210.8
10 years 114.84
Extreme 114.84280575
210.8
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%+0.64%+26.46%-20.38% 48.5B
+0.84%-3.74%-26.69%+1.85% 167B
-0.07%-2.55%-9.53%+11.07% 111B
+0.90%+1.13%-24.83%+0.58% 105B
-1.24%-1.31%-48.43%-13.54% 74.82B
-0.24%+0.69%+0.16%+72.58% 59.11B
-0.86%+4.49%+17.49%+57.78% 51.8B
-0.71%-3.82%-7.72%-31.41% 48.5B
+0.12%+0.97%-16.40%+18.55% 40.79B
-1.01%-2.41%+29.18%-8.51% 32.54B
Average -0.12%-0.16%-6.03%+8.86% 76.68B
Weighted average by Cap. +0.02%-0.91%-13.05%+7.90%

Financials

2026 *2027 *
Net sales 19.28B 17.13B 15.99B 14.57B 27.48B 1,853B 27.74B 193B 74.96B 947B 72.37B 70.8B 3,040B 19.73B 17.53B 16.36B 14.91B 28.13B 1,897B 28.39B 198B 76.74B 970B 74.09B 72.48B 3,112B
Net income 1.44B 1.28B 1.19B 1.09B 2.05B 138B 2.07B 14.42B 5.59B 70.6B 5.39B 5.28B 227B 2.34B 2.08B 1.94B 1.77B 3.34B 225B 3.37B 23.48B 9.1B 115B 8.78B 8.59B 369B
Net Debt 15.88B 14.11B 13.17B 12.01B 22.64B 1,527B 22.86B 159B 61.77B 781B 59.64B 58.35B 2,505B 13.95B 12.4B 11.57B 10.55B 19.89B 1,341B 20.07B 140B 54.25B 686B 52.38B 51.24B 2,200B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
-
Date Price Change
02/10/26 €157.00 -0.79%
01/10/26 €158.25 -0.25%
30/09/26 €158.65 -1.00%
29/09/26 €160.25 -0.96%
28/09/26 €161.80 +0.65%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
178.07USD
Average target price
195.67USD
Spread / Average Target
+9.88%

Quarterly revenue - Rate of surprise